businesspress24.com - MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, Augus
 

MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, August 7, 2012

ID: 1136384

(firmenpresse) - IRVINGTON, NY -- (Marketwire) -- 07/25/12 -- (NASDAQ: MELA), the medical device company that has developed and is commercializing ®, today announced that it will release its 2012 second quarter financial results after the close of trading on Tuesday, August 7, 2012. MELA Sciences executives will also host a conference call that day at 4:30 PM ET to discuss the results as well as provide a general business update.

Date: Tuesday, August 7, 2012
Time: 4:30 PM ET

To participate in the teleconference, please dial:
Domestic toll-free: (888) 240 9345
International: (913) 312 1513
Participant Code: 4218253

To listen via live webcast, please go to the investor relations section of the MELA Sciences website at approximately 10 minutes prior to the teleconference start time. If you are unable to participate during the live conference call and webcast, the conference call audio cast will be archived and available for replay for approximately 90 days.

MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind®, and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.

For more information on MELA Sciences, visit .






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  BIOLASE Establishes Inside Sales Group
Apira Science, Inc. Announces Successful Completion of Clinical Trial for the Treatment of Androgenetic Alopecia in Males
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 25.07.2012 - 08:21 Uhr
Sprache: Deutsch
News-ID 1136384
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

IRVINGTON, NY


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 174 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, August 7, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von

MELA Sciences (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MELA Sciences



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 167


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.